Sage Therapeutic Com (NQ: SAGE )
7.350
-0.090
(-1.21%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 10, 2024
Add to My Watchlist
Headline News about Sage Therapeutic Com
![](https://investorplace.com/wp-content/uploads/2019/08/cpb1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/08/07/tyson_foods_-_logo_0.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/03/shutterstock_143940730-1.jpg)
![](https://www.investors.com/wp-content/uploads/2022/02/Stock-sagetherapeutics-02-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_7892.jpeg?width=1200&height=800&fit=crop)
Expert Ratings for Sage Therapeutics
May 09, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Sage Therapeutics's Earnings Outlook
May 01, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
What 5 Analyst Ratings Have To Say About Sage Therapeutics
March 09, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/07/sage.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/07/wayfair_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/options_image_2.jpeg?width=1200&height=800&fit=crop)
10 Health Care Stocks Whale Activity In Today's Session
July 31, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/741314/stock-crashing.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_111.jpeg?width=1200&height=800&fit=crop)
Expert Ratings for Sage Therapeutics
December 06, 2022
Via Benzinga
Sage Therapeutics's Return On Capital Employed Insights
December 05, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/17/aapharma_4.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/13/sage.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/26/universal_health_services_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/13/image15.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_7522.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/13/image24.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/06/biib_co.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU5.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6692.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2022/08/A1-081522-depressionisland-adobe.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.